M. Di Leo

ORCID: 0000-0001-5477-8908
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Epilepsy research and treatment
  • Educational and Social Studies
  • Cancer Genomics and Diagnostics
  • Gastric Cancer Management and Outcomes
  • Pancreatic and Hepatic Oncology Research
  • Fetal and Pediatric Neurological Disorders
  • Health and Wellbeing Research
  • Diverse academic and cultural studies
  • Health Sciences Research and Education
  • Advances in Oncology and Radiotherapy
  • Myeloproliferative Neoplasms: Diagnosis and Treatment
  • Esophageal Cancer Research and Treatment
  • Neurology and Historical Studies
  • Chronic Myeloid Leukemia Treatments
  • Soft tissue tumor case studies
  • Tumors and Oncological Cases
  • Hedgehog Signaling Pathway Studies
  • Multiple Myeloma Research and Treatments
  • Oral and Maxillofacial Pathology
  • Neonatal and fetal brain pathology
  • Legal and Labor Studies
  • Economic and Financial Impacts of Cancer
  • EEG and Brain-Computer Interfaces
  • Polyomavirus and related diseases
  • Memory and Neural Mechanisms

Pitié-Salpêtrière Hospital
2024

Sorbonne Université
2024

Assistance Publique – Hôpitaux de Paris
2019-2024

Université Paris Cité
2019

Hôpital Beaujon
2019

Université Joseph Fourier
1994-1996

Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda
1996

Elmhurst Hospital Center
1996

NewYork–Presbyterian Hospital
1996

Cornell University
1996

Previous reports of ultrasonographically diagnosed seizure activity in utero have described fetuses with obvious, gross, tonic-clonic movements trunk and extremities. Three akinesia deformation sequence are described: two arthrogryposis multiplex congenita one Pena-Shokeir syndrome. Each was demonstrated by serial real-time ultrasound examinations to joint contractures, absent fetal breathing motions, lack gross other than sonographically evident subtle activity. Fetal can be when seen the...

10.1016/0029-7844(96)00097-x article EN Obstetrics and Gynecology 1996-10-01

Pancreatic ductal adenocarcinoma (PDAC) is the fourth leading cause of cancer death in United States with 41,615 deaths 2015 as well Europe where 128,000 persons are expected to die from this tumor 2018 [1,2].Although worldwide incidence low 4.2 per 100 000, and there important geographic differences (from 7.4 000 North America fewer than 1.5 Central Africa), rising developed countries such France, it nearly doubled between 1982 2012 ranges 10.2 men 6.9 women [3].Because mortality rate will...

10.15761/crr.1000184 article EN Cancer Reports and Reviews 2019-01-01
Coming Soon ...